Samsung Medical Center Reaches 1,500 Gastric Cancer Robotic Surgeries, Five-Year Survival Rate Hits 89.5%

[Financial News] The five-year relative survival rate for gastric cancer patients at Samsung Medical Center was 89.5%, far exceeding the averages for South Korea (78.6%) and the United States (37.9%).
Samsung Medical Center recently announced that it had performed 1,500 robotic surgeries for gastric cancer. The hospital has steadily increased the proportion of minimally invasive procedures to reduce patients' pain, bleeding and scarring. Of the 1,174 gastric cancer surgeries performed last year, 256 were robotic procedures, accounting for 22%.
Samsung Medical Center expects this growth to accelerate after recently introducing the latest robotic surgical system, da Vinci 5 (DV5), dedicated to gastrointestinal surgery.
Samsung Medical Center is the only hospital in South Korea equipped with a DV5 system dedicated to gastrointestinal surgery.
Lee Jun-ho, chief of gastrointestinal surgery, said, "The introduction of dedicated robotic equipment is expected to improve surgical techniques while maintaining treatment outcomes and quality of life for gastric cancer patients." He added, "We will devote ourselves to developing techniques that deliver better treatment outcomes for patients in the future."
Samsung Medical Center also expects treatment outcomes for gastric cancer patients to improve. The mortality rate within 90 days after surgery was 0.42%, about half the 0.98% average for tertiary general hospitals.
Lee Ji-yeon, director of the Gastric Cancer Center and a hematology-oncology specialist, stated, "By reaching a cumulative total of 1,500 robotic surgeries for gastric cancer, we have once again demonstrated our world-class competitiveness." She added, "We will open a new chapter in gastric cancer care through accurate diagnoses and optimal treatment."
 


[email protected] Medical Correspondent Jeong Myeong-jin Reporter